Predictive value of pentraxin-3 on disease severity and prognosis in patients with hemorrhagic fever with renal syndrome

Abstract Background: Pentraxin-3 is an acute-phase protein involved in the processes of inflammation and infection. This study aimed to analyze the changes of plasma pentraxin-3 prospectively and evaluate its predictive value on disease severity and prognosis in patients with hemorrhagic fever with renal syndrome (HFRS).Methods: A total of 105 HFRS patients were enrolled in this study and were grouped according to the clinical classification criteria for HFRS, and 27 healthy volunteers served as controls. The levels of plasma pentraxin-3 were detected using the enzyme linked immunosorbent assay (ELISA), and which were compared among the acute and convalescent phases in different types of patients, as well as the control group. Spearman correlation analysis was used to evaluate the correlation between pentraxin-3 and conventional laboratory indexes. The predictive effectiveness for prognosis of pentraxin-3 was evaluated by receiver operating characteristic (ROC) curve analysis.Results: There was no significant difference in gender and age distribution between all types of patients and control group (P>0.05). In all types of patients, the levels of pentraxin-3 in acute phase were significantly higher than that of control group and convalescent phase of the same type (P<0.05). The levels of pentraxin-3 increased with the aggravation of the disease, and showed the highest expression in critical-type patients (P<0.05). Pentraxin-3 was positively correlated with WBC, AST and APTT, and negatively correlated with PLT, ALB and Fib (|rs|>0.500, P<0.001). Pentraxin-3 showed significant predictive value for the prognosis of HFRS patients, with the area under ROC curve (AUC) of 0.753 (95%CI: 0.593~0.914, P=0.003).Conclusions: The detection of plasma pentraxin-3 can be beneficial to the evaluation of disease severity and prognosis in patients with HFRS.